News
New 3D printing research paves way for personalised medication
A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalised pills...
Bristol Myers Squibb’s CAR T cell therapy Breyanzi approved by U.S. Food and Drug...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers Squibb's Breyanzi ® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen...
AC Immune and Takeda sign agreement for active immunotherapy designed to delay Alzheimer’s disease...
Takeda and AC Immune have announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta...
